Discontinuation report TEVA-RABEPRAZOLE EC

Last updated on 2020-07-10 History
Report ID 120015
Drug Identification Number 02296640
Brand name TEVA-RABEPRAZOLE EC
Common or Proper name TEVA-RABEPRAZOLE 20MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-03-25
Remaining supply date 2020-03-25
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-07-10 French Compare
v1 2020-07-10 English Compare